| Frank Schoenen, Ph.D. » |
Exploiting ER stress pathway as a target of vulnerability in ovarian cancer |
University of New Mexico |
$29,026 |
3/1/2018 |
| David Davido, Ph.D. » |
Identification of novel HSV-1 ICP0 E3 ligase targets by mass spectrometry in neurons |
Virginia Polytechnic Institute and State University |
$189,375 |
3/15/2018 |
| Scott Lovell, Ph.D. » |
Chemical Tools for Perturbing Iron Homeostasis in P. aeruginosa |
Louisiana State University |
$57,501 |
3/29/2018 |
| Frank Schoenen, Ph.D. » |
Capitalizing on p53 loss/mutations in osteosarcoma by novel compounds |
KU Medical Center |
$101,372 |
4/1/2018 |
| Shi Fang Yan, Ph.D. » |
PINK1 signaling and synaptic mitochondria integrity in AD |
National Institutes of Health |
$416,625 |
4/1/2018 |
| Wendy Picking, Ph.D. » |
Vaccines to counter emerging antibiotic resistance |
National Institutes of Health |
$5,887,170 |
5/1/2018 |
| David Volkin, Ph.D. » |
HPV Preservatives Grant |
Gates Foundation |
$3,272,927 |
5/1/2018 |
| Yong Zeng, Ph.D. » |
Supplement: Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer |
National Institutes of Health |
$62,875 |
5/1/2018 |
| Scott Lovell, Ph.D. » |
Small Molecule Protease Inhibitors against MERS-CoV |
Kansas State University |
$64,372 |
5/15/2018 |
| Shirley ShiDu Yan, Ph.D. » |
Effect of Mitokinin (MTK-115) on Aβ and tau phosphorylation and mitochondrial function in vitro cultured neurons |
Mitokinin, Inc |
$47,644 |
5/20/2018 |
| Josephine Chandler, Ph.D. » |
Blocking quorum sensing to potentiate antibiotics in Pseudomonas aerugniosa |
J.R. & Inez W. Jay Fund |
$30,000 |
7/1/2018 |
| Audrey Lamb, Ph.D. » |
Staphylopine Biosynthesis as an Antimicrobial Target in Staphylococcus aureus Infective Endocarditis |
AHA - American Heart Association |
$53,688 |
7/1/2018 |
| Kristi Neufeld, Ph.D. » |
Novel Function of APC Tumor Suppressor in DNA Topoisomerase II-mediated Cell Cycle Checkpoint |
J.R. & Inez W. Jay Fund |
$30,000 |
7/1/2018 |
| Shirley ShiDu Yan, Ph.D. » |
Pink1 amyloid pathology, and mitochondrial quality control in Alzheimer's Disease |
National Institutes of Health |
$2,842,115 |
7/1/2018 |
